Search

Search Results

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  2583

  PDF: 1829

  HTML: 1098

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3791

  PDF: 2642

  HTML: 1685

• CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

  Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus

  e2023066

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.066

  3967

  PDF: 1591

  HTML: 360

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4680

  PDF: 1820

  HTML: 1340

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  3476

  PDF: 1014

  HTML: 4767

• PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics

  Xiaoqiang Zheng, Hongbing Rui, Ying Liu, Jinfeng Dong

  e2020073

  2020-11-02

  https://doi.org/10.4084/mjhid.2020.073

  944

  PDF: 169

  HTML: 233

• CLASSICAL HODGKIN LYMPHOMA TODAY

  Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.055

  1020

  PDF: 595

  HTML: 224

• THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.

  Francesco Maura, Lucia Farina, Paolo Corradini

  e2016045

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.045

  4221

  PDF: 1237

  HTML: 2121

  Fig.1: 248

  Fig. 2: 142

  Table 1: 254

  Table2: 275

  Table 3: 259

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

  Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori

  e2012075

  2012-11-07

  https://doi.org/10.4084/mjhid.2012.075

  2760

  PDF: 941

  HTML: 2141

• SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

  Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca

  e2016062

  2016-11-06

  https://doi.org/10.4084/mjhid.2016.062

  3951

  PDF: 1152

  HTML: 2570

• PATHOBIOLOGY OF HODGKIN LYMPHOMA

  Claudio Agostinelli, Stefano Pileri

  e2014040

  2014-06-05

  https://doi.org/10.4084/mjhid.2014.040

  3429

  PDF: 1572

  HTML: 5976

  Fig1-Ag-Pil: 287

  Ag-Pil Fig.2: 288

• CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

  guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv

  e2022066

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.066

  1244

  PDF: 719

  HTML: 279

• INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

  Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni

  e2016006

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.006

  4779

  PDF: 1425

  HTML: 2295

• EBV AND HIV-RELATED LYMPHOMA

  Michele Bibas, Andrea Antinori

  e2009032

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.032

  1707

  PDF: 692

  HTML: 7233

• CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

  Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone

  e2024010

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.010

  4740

  PDF: 3911

  HTML: 382

• OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

  Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

  e2023025

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.025

  1616

  HTML: 416

  PDF: 1025

  Suppl. Files: 523

• HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

  Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré

  e2014050

  2014-07-01

  https://doi.org/10.4084/mjhid.2014.050

  3058

  PDF: 1453

  HTML: 3741

  Untitled: 256

  Untitled: 260

  Untitled: 220

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2671

  PDF: 1803

  HTML: 728

• USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

  Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao

  e2022048

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.048

  1009

  PDF: 780

  HTML: 307

• NEW STRATEGIES FOR STEM CELL MOBILIZATION

  Roberto Lemoli

  e2012066

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.066

  2604

  PDF: 966

  HTML: 2586

• INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?

  Francesco Zallio, Giulia Limberti, Marco Ladetto

  e2017035

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.035

  3422

  PDF: 1111

  HTML: 2580

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2454

  PDF: 1910

  HTML: 1069

• PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

  Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus

  e2014053

  2014-07-04

  https://doi.org/10.4084/mjhid.2014.053

  3531

  PDF: 2100

  HTML: 7585

• FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

  Andrea Gallamini, Anna Borra

  e2017029

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.029

  3440

  PDF: 1348

  HTML: 2377

• Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

  Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi

  e2016060

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.060

  3609

  PDF: 862

  HTML: 3034

  Figure 1a and 1b: 205

  Figure 2: 214

  Figure 3: 218

  Figure 4: 209

  Figure 5: 205

  Tables 1-5: 185

• CUPROPTOSIS: A REVIEW ON MECHANISMS, ROLE IN SOLID AND HEMATOLOGICAL TUMORS, AND ASSOCIATION WITH VIRAL INFECTIONS

  MAURIZIO MARTINI, Pietro Tralongo, Mariagiovanna Ballato, Vincenzo Fiorentino, Walter Giordano, Valeria zuccalà, Cristina Pizzimenti, Arianna Bakacs, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Luigi Maria Larocca

  e2025052

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.052

  2015

  PDF: 1128

  HTML: 975

• NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

  Augustine Avilès

  e2015052

  2015-08-30

  https://doi.org/10.4084/mjhid.2015.052

  1876

  PDF: 1081

  HTML: 1892

  Tables: 222

• Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.

  John Ayodele Olaniyi

  e2011008

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.008

  2608

  PDF: 657

  HTML: 1211

• LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B

  Eva Eliassen, Gerhard R Krueger, Mario Luppi, Dharam Ablashi

  e2018035

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.035

  3929

  PDF: 1703

  HTML: 881

  Figures . Eliassian: 302

• NOVEL DRUGS IN FOLLICULAR LYMPHOMA

  Giuseppe Rossi, Antonella Anastasia

  e2016061

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.061

  5957

  PDF: 1612

  HTML: 1678

  Untitled: 284

• MOLECULAR MECHANISM OF TRAF6 IN MALIGNANT PROLIFERATION OF HUMAN NK/T CELL LYMPHOMA CELL HANK1

  Yan Qi, Chengbo Xu, Zesong Chen, Jiawei Chen, Congjie Chen

  e2025074

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.074

  668

  PDF: 368

  html: 141

• OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

  Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett

  e2018020

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.020

  3082

  PDF: 905

  HTML: 435

• CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

  Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti

  e2024045

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.045

  3923

  PDF: 1729

  HTML: 107

• TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

  Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD

  e2022018

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.018

  2076

  PDF: 858

  HTML: 621

• INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS)

  Alessandro Laganà, Raffaele Maglione, Alessandro Costa, Biancamaria Mandelli, Maria Laura Bisegna, Maria Laura Milani, Valeria Filipponi, Maria Grazia Nardacci, Tania Soriano, Eugenio Santacroce, Luigi Petrucci, Carla Giordano, Maurizio Martelli, Maria Stefania De Propris

  e2025.002

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.002

  2686

  PDF: 1659

  HTML: 484

  PDF: 1093

• NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

  Dimitar Efremov, Adrian Wiestner, Luca Laurenti

  e2012067

  2012-10-09

  https://doi.org/10.4084/mjhid.2012.067

  2693

  PDF: 909

  HTML: 9072

  Efremov 1: 277

  Efremov 2: 246

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

  Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

  e2024061

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.061

  3145

  PDF: 3402

  HTML: 797

• Persistent Fever and Splenic Abscess-like Lesions: A Diagnostic Trap in a Young Adult

  Chu Ee Seow, Siti Nur Atiqah Alwi, Nor Syazana Jamali, Sukanya Banerjee Nair

  e2026063

  2026-09-01

  https://doi.org/10.4084/MJHID.2026.063

  112

  PDF: 86

  Suppl. Files: 25

  Html: 67

  Html Suppl. Files: 18

• COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

  Surbhi Goyal, Usha Rani Singh, Usha Rusia

  e2014002

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.002

  2148

  PDF: 1153

  HTML: 52158

• UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS

  Mónica Cabrero, Alba Redondo, Alejandro Martin, Dolores Caballero

  e2012074

  2012-11-07

  https://doi.org/10.4084/mjhid.2012.074

  2278

  PDF: 809

  HTML: 1118

• Simultaneous dual pathology in lymph node

  Prakas Kumar Mandal, Supriyo Sarkar, Malay Kumar Ghosh, Maitreyee Bhattacharyya

  e2014036

  2014-05-31

  https://doi.org/10.4084/mjhid.2014.036

  1747

  PDF: 768

  HTML: 7858

  Simultaneous dual pathology in lymph node: 221

  Simultaneous dual pathology in lymph node: 237

  Simultaneous dual pathology in lymph node: 191

  Simultaneous dual pathology in lymph node: 234

  Simultaneous dual pathology in lymph node: 227

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2735

  PDF: 1720

  HTML: 2462

  Table1: 271

• CIRCCTNNA1 IS UPREGULATED IN MANTLE CELL LYMPHOMA AND PREDICTS POOR SURVIVAL BY SPONGING MIR-34A TO INCREASE CELL PROLIFERATION.

  Xuebing Jing, Cong Lu, Chao Song, Qingkun Han

  e2022047

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.047

  773

  PDF: 583

  HTML: 294

• CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

  omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad

  e2015049

  2015-08-25

  https://doi.org/10.4084/mjhid.2015.049

  1622

  PDF: 972

  HTML: 1028

  figures: 235

  table 1: 238

  table2: 237

  table3: 246

• POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

  Daniela Capello, Gianluca Gaidano

  e2009018

  https://doi.org/10.4084/mjhid.2009.018

  1447

  PDF: 504

  HTML: 18637

  Figure 1: 207

  Figure 2: 191

  Figure 3: 206

  Figure 4: 240

  Figure 5: 212

• IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE

  Francesco Di Raimondo, Giorgio La Nasa

  e2014039

  2014-05-29

  https://doi.org/10.4084/mjhid.2014.039

  2335

  PDF: 1060

  HTML: 1993

• TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

  PIMJAI NIPARUCK

  e2021063

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.063

  1321

  PDF: 629

  HTML: 284

• CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

  Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi

  e2009030

  https://doi.org/10.4084/mjhid.2009.030

  1446

  PDF: 646

  HTML: 4199

• CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

  Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

  e2024012

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.012

  2509

  PDF: 1969

  HTML: 189

• FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

  Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter

  e2023041

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.041

  1740

  PDF: 798

  HTML: 252